west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "刘浩" 122 results
  • ADVANCES OF RESEARCH ON REPAIR OF DEGENERATIVE INTERVERTEBRAL DISC WITH GENE TRANSDUCTION

    Objective To introduce the latest advances of research on repair of the degenerative intervertebral disc with gene transduction.Methods The recentlypublished articles about the treatment of degenerative disc with gene transduction were reviewed, especially the articles published during the recent 5 years about the application of this therapy to regulating the synthesisand degradation of the extracellular matrix of the degenerative intervertebral disc.Results The shape and function of the normal intervertebral disc were reported to be closely related to the synthesis and degradation of the extracellular matrix of the intervertebral disc. The extracellular matrix of the intervertebral disc was a target for the gene transduction to repair the degenerative intervertebral disc. There was a great development of the treatment with gene transduction, especially in vector choice, target gene transduction, and transgene regulation and safety. Conclusion The advances of the research have indicated that repair of the degenerative intervertebral disc with gene transduction is a keyto curing the disease of the degenerative intervertebral disc.

    Release date:2016-09-01 09:20 Export PDF Favorites Scan
  • Clinical outcomes of Hangman fracture treated by anterior cervical discectomy and fusion

    Objective To observe the clinical outcomes of Hangman fracture treated by anterior cervical discectomy and fusion. Methods A total of 41 patients with Hangman fracture were retrospectively analyzed, who underwent anterior cervical discectomy and fusion from May 2010 to May 2016. Intervertebral bone graft fusion was observed through postoperative radiographic images, and improvement of symptoms was evaluated by Visual Analogue Scale (VAS), Neck Disability Index (NDI) and Modified Japanese Orthopaedic Association Scale (m-JOA). Surgical complications were evaluated as well. Results No severe complications occurred after surgery, but 5 patients had a transient dysphagia, which relieved spontaneously. Thirty-five patients had a fusion of intervertebral bone graft 3 months after surgery, and the remaining 6 patients did at the last follow-up. The VAS score was improved from 4.5±1.6 pre-operatively to 2.4±1.7 immediately post-operatively (P>0.05), and was further improved to 0.7±0.9 at the last follow-up (P<0.05). The NDI score was improved from 29.3±10.9 pre-operatively to 13.2±5.4 immediately post-operatively (P<0.05), and was further improved to 4.6±3.1 at the last follow-up (P<0.05). The m-JOA score was improved from 8.4±2.3 pre-operatively to 11.6±3.5 immediately post-operatively (P<0.05), and was further improved to 14.3±2.0 at the last follow-up (P<0.05). Conclusion Anterior cervical discectomy and fusion can be used in Hangman fracture, which is safe and reliable.

    Release date:2017-11-24 10:58 Export PDF Favorites Scan
  • ADVANCES OF MESENCHYMAL STEM CELLS TRANSPLANTATION FOR TREATING INTERVERTEBRAL DISC DEGENERATION

    Objective To introduce the research of mesenchymal stemcells(MSCs) transplantation for treating intervertebral disc degeneration. Methods The recent original articles about the MSCs transplantation for treating intervertebral disc degeneration were extensively reviewed. Results Transplanted MSCs in intervertebral disc can express chrondcyte-like phenotype in certain conditions, increase matrix synthesis and release intervertebral disc degeneration. Conclusion MSCs transplantation for treating intervertebral disc degeneration may be a future approach.

    Release date:2016-09-01 09:22 Export PDF Favorites Scan
  • 生物活性因子治疗椎间盘退变性疾病的研究进展

    生物活性因子治疗是椎间盘退变性疾病生物治疗的重要组成部分,包括各类生长因子、炎性因子拮抗因子、生物酶类抑制剂及细胞内调节因子等,可通过不同途径对椎间盘内细胞功能进行调控。常用于椎间盘退变治疗的生物活性因子包括骨形态发生蛋白、转化生长因子 β、促有丝分裂因子和富血小板血浆等。生物活性因子发挥作用需一定的椎间盘微环境,即相当数量的有正常功能状态的椎间盘细胞、足够的营养支持及供氧条件。目前生物活性因子的应用仍存在可导致椎间盘骨化、软骨化等副作用,且缺少稳定可靠的给药途径。探索新的、有效的生物活性因子和其转化应用研究,以及不同生物治疗策略与生物活性因子的联合使用,是生物活性因子治疗椎间盘退变性疾病的重点和研究方向。该文对生物活性因子治疗椎间盘退变性疾病的研究进行了综述。

    Release date:2017-11-24 10:58 Export PDF Favorites Scan
  • TiNi环抱式接骨器内固定治疗多发性肋骨骨折

    目的 总结钛镍(TiNi)环抱式接骨器治疗多发性肋骨骨折的临床经验,分析其临床效果。 方法 2009年1月至2012年3月泸州医学院附属中医院收治115例多根多处肋骨骨折患者,采用随机化模块法将115例患者分为两组,内固定组:60例,男38例,女22例;年龄16~78岁;平均肋骨骨折数6.36根,部位4.56处;合并血气胸37例,28例伴有明显反常呼吸运动和急性呼吸窘迫综合征(ARDS);均采用钛镍(TiNi) 环抱式接骨器内固定,伴ARDS和呼吸功能不全者加用呼吸机辅助呼吸治疗。对照组:55例,男42例,女13例;年龄17~79岁,平均肋骨骨折数6.23根,部位4.72处,伴血气胸38例;用胸带加厚棉垫加压包扎外固定。术后观察两组患者的疼痛指数(VAS)、镇痛药用量、呼吸机带机时间、肺部并发症发生率和平均住院时间。 结果 所有患者均治愈出院,无围术期死亡。入院后安静时和强制咳嗽时各时间点两组VAS差异均有统计学意义(P<0.05)。内固定组患者疼痛明显减轻,镇痛药物(曲马多)用量、镇痛药物使用时间、肺不张、肺部感染等并发症发生率、呼吸机辅助呼吸时间和住院时间明显少于或短于对照组(P<0.05)。 结论 对多根多处肋骨骨折,特别是伴反常呼吸、呼吸功能不全患者,行TiNi环抱式接骨器内固定肋骨断端,临床效果满意,它是一种新型、实用、有效的肋骨固定方法。

    Release date:2016-08-30 05:47 Export PDF Favorites Scan
  • RESEARCH ADVANCES IN ANIMAL MODELS OF INTERVERTEBRAL DISC DEGENERATION

    Objective To review the research advances in animal models of human disc degeneration. Methods The relative articles in recent years were extensively reviewed. Studies both at home and abroad were analyzed and classified. The advantages and disadvantages of each method were compared. Results Studies were classified as either experimentally induced models or spontaneous models. The induced models were subdivided as mechanical (alteration of forces on the normal disc), structural (injury or chemical alteration) and genetically induced models. Spontaneous models included those animals that naturally developed degenerative disc disease. Conclusion Animal model of intervertebral disc degeneration is an important path for revealing the pathogenesis of human disc degeneration, and play an important role in testing novel interventions. With recent advances in the relevance of animal models and humans, it has a great prospect in study of human disc degeneration.

    Release date:2016-09-01 09:20 Export PDF Favorites Scan
  • PRELIMINARY APPLICATION OF ANTERIOR UNCOVERTEBRAL JOINT RESECTION IN CERVICAL SPONDYLOTIC TERATMENT

    Objective To investigate the effect and safety of the anterior uncovertebral joint resection in treatment of cervical spondylotic myelopathy accompanied by radiculopathy. Methods From March 2002 toJuly 2004, 9 patients (5 males, 4 females; aged 38-66) with cervical spondylotic myelopathy accompanied by radiculopathy underwent the anterior uncovertebral joint resection and discectomy using the titanium cage implantation. There were 6 unilateral and 3 bilateral compressed nerve roots. Results During the follow-up for 3-16 months, CT scanning or X-ray films revealed thatall the patients improved with an enlargement of the intervertebral foramen, and MRI demonstrated that compression of the spinal cord and nerve roots vanished.Seven patients had a relief in the radicular pain although the other 2 still had a residual pain. All the patients improved to some extent in symptoms of myelopathy. No patient suffered vertebral artery injury during the operation. Conclusion The uncovertebral joint resection can directly decompressthe nerve roots. The key to avoidance of an injury to the vertebral artery is agood understanding of the regional anatomy and a good performance of the operation. 

    Release date:2016-09-01 09:25 Export PDF Favorites Scan
  • THE CLINICAL SIGNIFICANCE OF MONITORING CARBOHYDRATE ANTIGEN CA50 IN PATIENTS WITH COLORECTAL CARCINOMA

    In order to investigate the possible involvement of the antigen CA50 in patients with colorectal carcinoma, the carbohydrated antigen CA50 in serum was examined in 30 normal individual, 27 patients with benign colorectal diseases and 66 patients with colorectal carcinoma by immunoradiometric assay (IRMA). The results showed that the serum CA50 in patients with colorectal carcinoma was significantly higher than that in patients with benign colorectal diseases and normal individual (P<0.01). It was significantly declined after radical operation (P<0.01). However, no significant change was noted after palliative operation (P>0.05) and elevation was noted in patients with tumor recurrence. The results suggest that the measurement of serum CA50 may be an useful marker for diagnosis and prognostic evaluation in patients with colorectal carcinoma.

    Release date:2016-08-29 09:16 Export PDF Favorites Scan
  • Meta-analysis of sequential efficacy of intranasal high-flow oxygen therapy versus non-invasive mechanical ventilation in invasive mechanical ventilation

    Objective To compare the sequential efficacy of high-flow nasal cannula oxygen therapy (HFNC) with non-invasive mechanical ventilation (NIV). Methods Randomized controlled trials comparing the efficacy of NIV sequential invasive mechanical ventilation with HFNC were included in the Chinese Journal Full-text Database, VIP Journal database, Wanfang Database, Chinese Biomedical Literature Database, PubMed, Cochrane Library and Embase. Meta-analysis was performed using RevMan5.4 software. Results A total of 2404 subjects were included in 19 studies. Meta-analysis results showed that compared with NIV, HFNC had a statistically significant difference in reducing patients' re-intubation rate in invasive mechanical ventilation sequence [relative risk (RR)=0.65, 95% confidence interval (CI) 0.50 - 0.86, Z=3.10, P=0.002]. HFNC showed statistically significant difference compared with NIV in reducing lung infection rate (RR=0.40, 95%CI 0.21 - 0.79, Z=2.67, P=0.008). HFNC was significantly different from NIV in terms of length of stay in Intensive Care Unit (ICU) (MD=–5.77, 95%CI –7.64 - –3.90, Z=6.05, P<0.00001). HFNC was significantly different from NIV in improving 24 h oxygenation index (MD=13.16, 95%CI 8.77 - 17.55, Z=5.87, P<0.00001). There was no significant difference in ICU mortality between HFNC and NIV (RR=0.70, 95%CI 0.45 - 1.08, Z=1.61, P=0.11). Conclusion Compared with NIV, sequential application of HFNC in invasive mechanical ventilation can improve the reintubation rate and pulmonary infection rate to a certain extent, reduce the length of ICU stay and improve the 24 h oxygenation index, while there is no difference in ICU mortality, which is worthy of clinical application.

    Release date:2023-04-28 02:38 Export PDF Favorites Scan
  • Evidence for Use of Bone Morphogenetic Protein in Lumbar Spine Arthrodesis

    Objective To evaluate the effectiveness, safety, cost and optimal dosing regimen of bone morphogenetic protein (BMP) used in the lumbar spine arthrodesis. Methods We formulated the clinical questions according to the PICO principle. We searched the ACP Journal Club (1991 to February 2008), The Cochrane Library (Issue 4, 2007) and PubMed (1990 to February 2008) as well as other relevant databases. The evidence retrieved was critically appraised. Results Current evidence showed that BMP was a satisfactory and safe behavior in lumbar arthrodesis. Its cost was equal to that of autogenous iliac bone graft. The types of BMP currently used in clinical practice are BMP-2 and BMP-7. Finished product of fixed composition ratio was recommended in anterior lumbar inter-body fusion, while in posterolateral fusion, 20mg of BMP-2 or 3.5mg of BMP-7 for each side was recommended, with proper carrier according to the place where it was used. Conclusion BMP may be introduced to China for lumbar spine arthrodesis. Before it is applied extensively, further large-scale, high-quality randomized controlled trials are needed. Meanwhile, more research is necessary to determine the proper dosage and preparation form for the dominant Chinese population.

    Release date:2016-09-07 02:13 Export PDF Favorites Scan
13 pages Previous 1 2 3 ... 13 Next

Format

Content